Treatment of fetal alcohol spectrum disorders: Are we ready yet?

Journal of Clinical Psychopharmacology

Volumn 29, Issue 1, 2009, Pages 1-4

  Burd, Larry ^a   Christensen, Trent ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; BUSPIRONE; CARBAMAZEPINE; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; FLUVOXAMINE; GUANFACINE; IMIPRAMINE; LITHIUM; LOXAPINE SUCCINATE; METHYLPHENIDATE; PEMOLINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; VALPROIC ACID;

ACADEMIC ACHIEVEMENT; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; COMORBIDITY; DISEASE PREDISPOSITION; EDITORIAL; FETAL ALCOHOL SYNDROME; HIGH RISK POPULATION; HUMAN; IMPULSIVENESS; OPPOSITIONAL DEFIANT DISORDER; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SOCIAL EVOLUTION; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; DEVELOPMENTAL DISORDER; DRINKING BEHAVIOR; FEMALE; MENTAL DEFICIENCY; PREGNANCY;

ALCOHOL DRINKING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DEVELOPMENTAL DISABILITIES; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; MENTAL RETARDATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 62649141004     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318192eaeb     Document Type: Editorial

References (23)

1. Floyd RL, Sidhu JS. Monitoring prenatal alcohol exposure. Am J Med Genet C Semin Med Genet. 2004;127:3-9.
2. Hoyme HE, May PA, Kalberg WO, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics. 2005;115:39-47.
3. May PA, Brooke L, Gossage JP, et al. Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. Am J Public Health. 2000;90:1905-1912.
4. May PA, Gossage JP, Marais AS, et al. The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug Alcohol Depend. 2007;88:259-271.
5. Abel EL. Fetal alcohol syndrome in families. Neurotoxicol Teratol. 1988;10:1-2.
6. Streissguth AP, Bookstein FL, Barr HM, et al. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25:228-238.
7. Burd L, Carlson C, Kerbeshian J. Fetal alcohol spectrum disorders and mental illness. Int J Disabil Human Dev. 2007;6:383-396.
8. Sampson PD, Streissguth AP, Bookstein FL, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997;56:317-326.
9. Streissguth AP, Aase JM, Clarren SK, et al. Fetal alcohol syndrome in adolescents and adults. JAMA. 1991;265:1961-1967.
10. Burd L, Klug M, Martsolf J, et al. Fetal alcohol syndrome: neuropsychiatric phenomics. Neurotoxicol Teratol. 2003;25:697-705.
11. Doig J, McLennan JD, Gibbard WB. Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder. J Child Adolesc Psychopharmacol. 2008;18:365-371.
12. Coe J, Sidders J, Riley K, et al. A survey of medication responses in children and adolescents with fetal alcohol syndrome. Ment Health Aspects Dev Disabil. 2001;4:148-155.
13. O'Malley KD, Koplin B, Dohner VA. Psychostimulant clinical response in fetal alcohol syndrome. Can J Psychiatry. 2000;45:90-91.
14. Snyder J, Nanson J, Snyder R, et al. A study of stimulant medication in children with FAS. In: Streissguth A, Kanter J, eds. The Challenge of Fetal Alcohol Syndrome: Overcoming Secondary Disabilities. Seattle, WA: University of Washington Press; 1997:64-77.
15. Oesterheld JR, Kofoed L, Tervok R, et al. Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc Psychopharmacol. 1998;8:39-48.
16. O'Connor MJ, Frankel F, Paley B, et al. A controlled social skills training for children with fetal alcohol spectrum disorders. J Consult Clin Psychol. 2006;74:639-648.
17. Kable JA, Coles CD, Taddeo E. Socio-cognitive habilitation using the math interactive learning experience program for alcohol-affected children. Alcohol Clin Exp Res. 2007;31:1425-1434.
18. Toutain S, Lejeune C. Family management of infants with fetal alcohol syndrome or fetal alcohol spectrum disorders. J Dev Phys Disabil. 2008;20:425-436.
19. Grant T, Ernst C, Streissguth A. Intervention with high-risk alcohol and drug abusing mothers. I. Administrative strategies of the Seattle model of paraprofessional advocacy. J Community Psychol. 1999;27:1-18.
20. Burd L, Deal E, Rios R, et al. Congenital heart defects and fetal alcohol spectrum disorders. Congenital Heart Dis. 2007;2:250-255.
21. Burd L, Klug MG, Bueling R, et al. Mortality rates in subjects with fetal alcohol spectrum disorders and their siblings. Birth Defects Research Part A. Clin Mol Teratol. 2008;82(4):217-223.
22. Habbick BF, Nanson JL, Snyder RE, et al. Mortality in fetal alcohol syndrome. Can J Public Health. 1997;88:181-183.
23. Burd L, Wilson H. Fetal, infant, and child mortality in a context of alcohol use. Am J Med Genet C Semin Med Genet. 2004;127:51-58.